Loss of p53 enhances the tumor-initiating potential and drug resistance of clonogenic multiple myeloma cells

Abstract excerpt

Tumor relapse and drug resistance are major factors that limit the curability of multiple myeloma (MM). New regimens have improved overall MM survival rates, but patients with high-risk features continue to have inferior outcomes. Chromosome 17p13 deletion (del17p) that includes the loss of the TP53 gene is a high-risk cytogenetic abnormality and is associated with poor clinical outcomes owing to relatively short...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Mechanisms and Therapy
• Share to Histone Deacetylase Inhibitors Research
• Share to Multiple Myeloma Research and Treatments